Regulation of Extrinsic Pathway Factor Xa Formation by Tissue Factor Pathway Inhibitor*
暂无分享,去创建一个
[1] Y. Nemerson,et al. An ordered addition, essential activation model of the tissue factor pathway of coagulation: evidence for a conformational cage. , 1986, Biochemistry.
[2] K. Mann,et al. Extrinsic pathway proteolytic activity. , 1993, Methods in enzymology.
[3] J. Miletich,et al. The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action , 1988 .
[4] G. David. Solid state lactoperoxidase: a highly stable enzyme for simple, gentle iodination of proteins. , 1972, Biochemical and biophysical research communications.
[5] D. Branam,et al. Importance of Substrate Composition, pH and Other Variables on Tissue Factor Enhancement of Factor Vlla Activity , 1993, Thrombosis and Haemostasis.
[6] S. Krishnaswamy,et al. The activation of prothrombin by the prothrombinase complex. The contribution of the substrate-membrane interaction to catalysis. , 1994, The Journal of biological chemistry.
[7] S. Rapaport,et al. Isolation and characterization of human factor VII. Activation of factor VII by factor Xa. , 1981, The Journal of biological chemistry.
[8] A. Guha,et al. Tissue factor and its extracellular soluble domain: the relationship between intermolecular association with factor VIIa and enzymatic activity of the complex. , 1992, Biochemistry.
[9] P. V. von Hippel,et al. Calculation of protein extinction coefficients from amino acid sequence data. , 1989, Analytical biochemistry.
[10] K. Fujikawa,et al. The mechanism of activation of bovine factor X (Stuart factor) by intrinsic and extrinsic pathways. , 1974, Biochemistry.
[11] J Jesty,et al. Kinetics of the inhibition of factor Xa and the tissue factor-factor VIIa complex by the tissue factor pathway inhibitor in the presence and absence of heparin. , 1994, Biochemistry.
[12] H. Hemker,et al. Kinetics of the inhibition of human factor Xa by full-length and truncated recombinant tissue factor pathway inhibitor. , 1994, The Biochemical journal.
[13] G. Broze,et al. Tissue factor pathway inhibitor and the revised theory of coagulation. , 1995, Annual review of medicine.
[14] G. Broze,et al. Kinetics of factor Xa inhibition by tissue factor pathway inhibitor. , 1993, The Journal of biological chemistry.
[15] P. Neuenschwander,et al. Factor VII autoactivation proceeds via interaction of distinct protease-cofactor and zymogen-cofactor complexes. Implications of a two-dimensional enzyme kinetic mechanism. , 1993, The Journal of biological chemistry.
[16] W. Ruf,et al. Identification of surface residues mediating tissue factor binding and catalytic function of the serine protease factor VIIa. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[17] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.
[18] U. Pendurthi,et al. Mechanism of antithrombin III inhibition of factor VIIa/tissue factor activity on cell surfaces. Comparison with tissue factor pathway inhibitor/factor Xa-induced inhibition of factor VIIa/tissue factor activity. , 1995, Blood.
[19] E. Davie,et al. Activation of human factor X (Stuart factor) by a protease from Russell's viper venom. , 1977, Biochemistry.
[20] Y. Nemerson,et al. The tissue factor pathway of blood coagulation. , 1992, Progress in hemostasis and thrombosis.
[21] J. Mason,et al. HYDRODYNAMIC ANALYSIS OF EGG PHOSPHATIDYLCHOLINE VESICLES , 1978, Annals of the New York Academy of Sciences.
[22] K. Mann,et al. Activation of human prothrombin by human prothrombinase. Influence of factor Va on the reaction mechanism. , 1987, The Journal of biological chemistry.
[23] D. Rader,et al. Plasma antigen levels of the lipoprotein-associated coagulation inhibitor in patient samples. , 1991, Blood.
[24] Y. Nemerson,et al. Surface-mediated enzymatic reactions: simulations of tissue factor activation of factor X on a lipid surface. , 1995, Biophysical journal.
[25] K Fujikawa,et al. The coagulation cascade: initiation, maintenance, and regulation. , 1991, Biochemistry.
[26] G. Nelsestuen,et al. Interaction of prothrombin and blood-clotting factor X with membranes of varying composition. , 1977, Biochemistry.
[27] G. Broze. Binding of human factor VII and VIIa to monocytes. , 1982, The Journal of clinical investigation.
[28] P. Coleman,et al. Assay of coagulation proteases using peptide chromogenic and fluorogenic substrates. , 1981, Methods in enzymology.
[29] Y. Nemerson,et al. Factor VII binding to tissue factor in reconstituted phospholipid vesicles: induction of cooperativity by phosphatidylserine. , 1986, Biochemistry.
[30] J. Morrison,et al. Methotrexate, a high-affinity pseudosubstrate of dihydrofolate reductase. , 1979, Biochemistry.
[31] P. Neuenschwander,et al. Roles of the membrane-interactive regions of factor VIIa and tissue factor. The factor VIIa Gla domain is dispensable for binding to tissue factor but important for activation of factor X. , 1994, The Journal of biological chemistry.
[32] K. Norris,et al. Recombinant human extrinsic pathway inhibitor. Production, isolation, and characterization of its inhibitory activity on tissue factor-initiated coagulation reactions. , 1990, The Journal of biological chemistry.
[33] S Krishnaswamy,et al. The interaction of human factor VIIa with tissue factor. , 1992, The Journal of biological chemistry.
[34] R J Baugh,et al. Role of the Activation Peptide Domain in Human Factor X Activation by the Extrinsic Xase Complex* , 1996, The Journal of Biological Chemistry.
[35] Susan G. Brown,et al. Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor , 1989, Nature.
[36] Kenneth G. Mann,et al. Surface-dependent reactions of the vitamin K-dependent enzyme complexes , 1990 .
[37] J. Miletich,et al. Monoclonal anti-human factor VII antibodies. Detection in plasma of a second protein antigenically and genetically related to factor VII. , 1985, The Journal of clinical investigation.
[38] G. Vlasuk,et al. Assembly of the prothrombinase complex enhances the inhibition of bovine factor Xa by tick anticoagulant peptide. , 1994, Biochemistry.
[39] V. Storme,et al. High–Level Secretion and Very Efficient Isotopic Labeling of Tick Anticoagulant Peptide (TAP) Expressed in the Methylotrophic Yeast, Pichia pastoris , 1994, Bio/Technology.
[40] J. Miletich,et al. Purification and properties of heparin-releasable lipoprotein-associated coagulation inhibitor. , 1991, Blood.
[41] G. Willems,et al. Kinetics of the Inhibition of Tissue Factor-Factor Vila by Tissue Factor Pathway Inhibitor , 1995, Thrombosis and Haemostasis.
[42] S. Rapaport,et al. The Tissue Factor Pathway: How It Has Become a “Prima Ballerina” , 1995, Thrombosis and Haemostasis.
[43] P. Kuzmič,et al. Program DYNAFIT for the analysis of enzyme kinetic data: application to HIV proteinase. , 1996, Analytical biochemistry.
[44] G. Broze,et al. Tissue factor pathway inhibitor , 1997 .
[45] N. Callander,et al. Mechanisms of binding of recombinant extrinsic pathway inhibitor (rEPI) to cultured cell surfaces. Evidence that rEPI can bind to and inhibit factor VIIa-tissue factor complexes in the absence of factor Xa. , 1992, The Journal of biological chemistry.
[46] K. Mann,et al. Role of the membrane surface in the activation of human coagulation factor X. , 1992, The Journal of biological chemistry.
[47] J. Shafer,et al. Reaction pathway for inhibition of blood coagulation factor Xa by tick anticoagulant peptide. , 1992, Biochemistry.
[48] E. Shaw,et al. [2] Titration of trypsin, plasmin, and thrombin with p-nitrophenyl p′-guanidinobenzoate HCl☆ , 1970 .
[49] H. Hess,et al. Assay of inorganic and organic phosphorus in the 0.1-5 nanomole range. , 1975, Analytical biochemistry.